tradingkey.logo

Accuray Inc

ARAY
View Detailed Chart
0.620USD
+0.020+3.32%
Close 02/06, 16:00ETQuotes delayed by 15 min
70.27MMarket Cap
LossP/E TTM

Accuray Inc

0.620
+0.020+3.32%
Intraday
1m
30m
1h
D
W
M
D

Today

+3.32%

5 Days

-23.20%

1 Month

-30.28%

6 Months

-52.67%

Year to Date

-24.81%

1 Year

-76.95%

View Detailed Chart

TradingKey Stock Score of Accuray Inc

Currency: USD Updated: 2026-02-06

Key Insights

Accuray Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 74 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 2.52.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Accuray Inc's Score

Industry at a Glance

Industry Ranking
74 / 205
Overall Ranking
204 / 4521
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Accuray Inc Highlights

StrengthsRisks
Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Overvalued
The company’s latest PE is -2.09, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 79.19M shares, decreasing 0.02% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 10.25K shares of this stock.

Analyst Rating

Based on 2 analysts
Strong Buy
Current Rating
2.525
Target Price
+320.76%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Accuray Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Accuray Inc Info

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments for complex cases. Its solutions are designed to advance patient care: during each individual treatment, throughout the treatment process, and at each stage of the cancer treatment journey, from curative to palliative treatments. Its technologies, the CyberKnife and TomoTherapy platforms, including the Radixact System, its TomoTherapy platform, are designed to deliver advanced treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), and adaptive radiation therapy (ART). In addition to these products, it also provides services, which include post-contract customer support (warranty period services and post-warranty services), installation services, training, and other professional services.
Ticker SymbolARAY
CompanyAccuray Inc
CEOLa Neve (Stephen R)
Websitehttps://www.accuray.com/
KeyAI